Treatment Information

Back

Ovarian Cancer treatment details. Immunotherapy.

University of Arizona Cancer Center, Tucson, AZ, United States.

Survival: monthsCountry:United States
Toxiciy Grade:3City/State/Province:Tucson, AZ
Treatments:ImmunotherapyHospital:University of Arizona Cancer Center
Drugs:Journal:Link
Date:Sep 2005

Description:

Patients: This phase III study involved 70 evaluable patients women with stage III ovarian cancer. Half the patients received the treatment and half received a placebo.

Treatment: The treatment consisted of immunotherapy - alpha-interferon.

Toxicity: Grade 3 toxicities included abdominal pain/cramping, diarrhea, fatigue, headache, nausea, pain, and vomiting.

Results: Median survival was not reported because it had not yet been reached.

Correspondence: David S. Alberts, MD





Back